CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma

Published:2011-10-15 Issue:4 Volume:61 Page:561-571
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Hong Sungyoul,Qian Jianfei,Li Haiyan,Yang Jing,Lu Yong,Zheng Yuhuan,Yi Qing

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-011-1123-2.pdf

Reference44 articles.

1. Palumbo A, Anderson K (2011) Multiple myeloma. N Engl J Med 364(11):1046–1060

2. Kyle RA, Rajkumar SV (2008) Multiple myeloma. Blood 111(6):2962–2972

3. Yi Q (2009) Novel immunotherapies. Cancer J 15(6):502–510

4. Yi Q (2003) Immunotherapy in multiple myeloma: current strategies and future prospects. Expert Rev Vaccines 2(3):391–398

5. Houot R, Levy R (2009) Vaccines for lymphomas: idiotype vaccines and beyond. Blood Rev 23(3):137–142

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laboratory Mice – A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma;Frontiers in Immunology;2021-06-02

2. Multiple myeloma presenting as cutaneous leukocytoclastic vasculitis and eosinophilia disclosing a T helper type 1/T helper type 2 imbalance: a case report;Journal of Medical Case Reports;2018-10-31

3. Increased cycles of DC/CIK immunotherapy decreases frequency of Tregs in patients with resected NSCLC;International Immunopharmacology;2017-11

4. Enhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy females;Experimental and Therapeutic Medicine;2017-02-21

5. Personalized Peptide Vaccine for Advanced Pancreatic Cancer;Pancreatic Cancer;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3